首页> 外文期刊>RSC Advances >Diastereoselective synthesis of novel spiro indanone fused pyrano[3,2-c] chromene derivatives following hetero-Diels-Alder reaction and in vitro anticancer studies
【24h】

Diastereoselective synthesis of novel spiro indanone fused pyrano[3,2-c] chromene derivatives following hetero-Diels-Alder reaction and in vitro anticancer studies

机译:新型螺吲哚通融合吡喃[3,2-C]铬衍生物的非对映选择性合成杂种蛋白 - 桤木反应和体外抗癌研究

获取原文
获取原文并翻译 | 示例

摘要

The development of concise methods for the synthesis of small functionalised spirocyclic molecules is important in the search of new bioactive molecules. To contribute this, here we represent a diastereoselective oxa-hetero-Diels-Alder reaction for the synthesis of novel spiro indanone fused pyrano[3,2-c] chromene derivatives and studied their in vitro anticancer activities. Using previously less explored cyclic ketone i.e. indane-1,3-dione and 3-vinyl-2H-chromene derivatives, we obtained novel spiro-heterocyclic frameworks at the interphase between "drug-like" molecules and natural products. Various spiro indanone fused pyrano[3,2-c] chromene derivatives were synthesized regiospecifically bearing a quaternary stereocenter in high yields (up to 85%) with excellent diastereoselectivity in toluene using 4 angstrom MS as additive under reflux condition at 120 degrees C. In vitro cytotoxic studies of these compounds against MCF-7 (breast cancer), HCT-116 (colon cancer), H-357 (oral cancer), MD-MB-231(Breast cancer) cell lines were evaluated by MTT {3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide} assay in vitro. The screening results revealed that many of the compounds are showing moderate to high levels of anticancer activities against the tested cancer cell lines and some displayed potent inhibitory activities in comparison to the commercial anticancer drug 5-fluorouracil (5-FU). Among the series, compound 3'c showed most potent cytotoxicity (15.0-27.5 mu M) in three cancer cell lines (MCF-7, HCT-116 and MD-MB-231).
机译:在寻找新的生物活性分子的搜索中,对小型功能化螺环分子合成的简明方法的发展在寻找新的生物活性分子中是重要的。为了贡献这一点,在这里,我们代表了对新型螺吲哚酮融合的吡喃[3,2-C]铬衍生物合成的非对映选择性的Oxa杂蛋白 - Ald反应,并研究了它们的体外抗癌活性。使用先前更少探索的环状酮I.e.Indane-1,3-二酮和3-乙烯基-2H-铬衍生物,我们在“药物状”分子和天然产物之间的间环之间获得了新的螺杂环骨架。各种螺茚满熔吡喃[3,2-C]铬衍生物在高产率(高达85%)中,在甲苯中具有优异的甲苯的季型立体封闭体,使用4埃作为添加剂,在回流条件下在120℃下进行极佳的甲苯。通过MTT {3-(3-()评估这些化合物对MCF-7(乳腺癌),HCT-116(结肠癌),H-357(口腔癌),MD-MB-231(乳腺癌)细胞系的含有细胞毒性研究。 4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴溴化镓体外测定。筛查结果表明,许多化合物均显示对测试癌细胞系的中等至高水平的抗癌活性,与商业抗癌药物5-氟尿嘧啶(5-FU)相比,一些显示的有效抑制活性。在该系列中,化合物3'C在三种癌细胞系(MCF-7,HCT-116和MD-MB-231)显示最有效的细胞毒性(15.0-27.5μm)。

著录项

  • 来源
    《RSC Advances》 |2018年第30期|共13页
  • 作者单位

    Ravenshaw Univ Dept Chem Cuttack Odisha India;

    Ravenshaw Univ Dept Chem Cuttack Odisha India;

    Ravenshaw Univ Dept Chem Cuttack Odisha India;

    Ravenshaw Univ Dept Chem Cuttack Odisha India;

    Kalinga Inst Ind Technol Sch Biotechnol Canc Biol Div Campus 11 Bhubaneswar 751024 Odisha India;

    Kalinga Inst Ind Technol Sch Biotechnol Canc Biol Div Campus 11 Bhubaneswar 751024 Odisha India;

    Kalinga Inst Ind Technol Sch Biotechnol Canc Biol Div Campus 11 Bhubaneswar 751024 Odisha India;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号